Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
sodium alginate + sodium bicarbonate + calcium carbonate (Farmayala Pharmaceutical Company S.A.)
- Development stage
- Unknown
- Lead developer
- Farmayala Pharmaceutical Company
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Digeril Reflux Pocket is an over-the-counter (OTC) oral suspension combination product used for the symptomatic relief of gastroesophageal reflux disease (GERD), heartburn, and acid indigestion. It contains sodium alginate, sodium bicarbonate, and calcium carbonate. The mechanism of action is dual-purpose: the sodium alginate reacts with gastric acid to form a physical alginate gel barrier (often called a "raft") that floats on top of the stomach contents to prevent acid reflux into the esophagus, while the sodium bicarbonate and calcium carbonate act as antacids to neutralize excess stomach acid. The product is marketed by Corporación Farmayala, a pharmaceutical company based in Ecuador, and is typically packaged in portable sachets for convenient use.
- Brand names
- Digeril Reflux PocketDigeril RefluxDigeril
- Other names
- Digeril Reflux Suspension
Beyond the preview
Go deeper on sodium alginate + sodium bicarbonate + calcium carbonate (Farmayala Pharmaceutical Company S.A.).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on sodium alginate + sodium bicarbonate + calcium carbonate (Farmayala Pharmaceutical Company S.A.).